Purpose

The goal of this study is to test a 6-week virtual education program among Black breast cancer survivors. The virtual program includes sessions on physical activity, goal setting, nutrition, sleep, stress, and social connections.

Conditions

Eligibility

Eligible Ages
Over 22 Years
Eligible Genders
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Female - Self-identified Black or African American race - Age 22-79 - Diagnosis of Stage I, II, or III invasive breast cancer - Completed active treatment at least 6 months ago, but within the past five years - Speaks English

Exclusion Criteria

  • Undergoing active treatment (i.e., surgery, chemotherapy, radiation) - Undergoing evaluation for suspected recurrence

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Supportive Care
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Breast Cancer Survivor Education Program
Participants will complete study procedures as outlined: - 6 weekly sessions of a modified version of the PAVING the Path to Wellness education program.
  • Behavioral: Breast Cancer Survivor Education Program
    Weekly sessions via Zoom platform with study staff.

Recruiting Locations

Massachusetts General Hospital Cancer Center
Boston, Massachusetts 02215
Contact:
Erica Warner, MPH, ScD
617-724-9516
ewarner@mgh.harvard.edu

More Details

Status
Recruiting
Sponsor
Massachusetts General Hospital

Study Contact

Erica Warner, MPH, ScD
617-724-9516
ewarner@mgh.harvard.edu

Detailed Description

This six-week feasibility study will evaluate a virtual support and education program among up to 15 Black female breast cancer survivors. Participants will be asked to attend a 90 minute group session once a week for 6 weeks and complete surveys pre and post intervention surveys to ascertain study endpoints. This study is supported by funding from Pfizer and in-kind support from the American Cancer Society, Inc.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.